comprehensive -WSS

comprehensive

author：focus 2025-09-30 20:35:11 - browse：7

om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry — Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Sana to lay off nearly a third of staff, de

focus

WSS

FDA panel signals lack of confidence in Amgen cancer drug data

Stroke deaths set to near 10 million globally by 2050

After John Oliver segment, STAT readers share their opioid

Novo acquires Inversago for up to $1 billion

Where are patients getting their prescriptions for GLP

Liquid biopsy for lung cancer is launched by Delfi

focus

comprehensive

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

After affirmative action ruling, medical educators look to 'holistic review'

Stroke deaths set to near 10 million globally by 2050

Peter Hotez and the public health issue of online harassment

Was Amgen transparent enough on FDA's concern on cancer drug?

United colonoscopy coverage change 'may cost lives,' doctors say

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Virginia high school admissions case could be legal follow

Target recalls 2.2 million additional candles due to laceration, burn hazards

hotspot

Timeline: Special counsel's investigation into Trump's handling of classified documents

Large hospital system sues Multiplan for low

Analysis of telehealth claims data suggest service duplication

VC firm General Catalyst wants to buy a health system

White House drug shortages task force keeps mum with Congress

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

knowledge

focus

focus

leisure time